You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., June 26, 2014 /PRNewswire/ -- Astellas announces the appointment of Marty Golden, J.D. as vice president, Government Affairs, which is effective on July 1, 2014. In this role, Golden will lead Federal Government Affairs, State Government Affairs, Therapeutic Area Government Strategy, and Corporate Government Strategy for Astellas in the Americas. Golden will report to Percival Barretto-Ko, senior vice president, Corporate Strategy and Government Affairs.
"Marty's proven track-record of success, rare blend of commercial and legal expertise, and in-depth knowledge of the pharmaceutical industry and the intricacies involved in navigating government and policy issues will be extremely beneficial," said Barretto-Ko. "As Astellas continues to grow in the Americas region, Marty will ensure that the development and implementation of proactive policy strategies will continue to align with and advance our business goals. He will be joining and leading a team of highly respected and accomplished individuals in the Government Affairs organization."
Most recently, Golden served as vice president, Hospital and Transplant Sales for Astellas. Golden joined Astellas in 2006 and has also held roles in New Product Planning and Strategy. Prior to joining Astellas, Golden held a number of positions with increasing responsibility across several disciplines for Novartis, Johnson & Johnson and Bristol-Myers Squibb. Golden holds a Juris Doctor degree from John Marshall Law School in Chicago, a Bachelor of Business Administration from the University of Iowa in Iowa City, Iowa, and a Master of Business Administration from Northwestern University-Kellogg School of Management, Evanston, Ill.
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at www.astellas.us. You can also follow us on Twitter at @AstellasUS.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.